Research Paper Volume 16, Issue 16 pp 11955—11969
Comprehensive multi-omics analysis reveals a combination of lncRNAs that synergistically regulate glycolysis and immunotherapeutic effects in renal clear cell carcinoma
Figure 4. Immunotherapy. (A) Proportion of common immune checkpoints between high- and low-risk groups. patient survival curves between HRL characteristics and PD-L1 (B), PD-1 (C), and CTLA4 (D) stratification. (E) Correlation of immune checkpoint genes with risk scores. (F) TIDE scores in the high-risk and low-risk groups. (G) IPS scores for PD-1 and CTLA4 co-blockers in the high-risk and low-risk groups. *p < 0.05, **p < 0.01, ***p < 0.001.